New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ono Pharmaceutical Co., Ltd.
OPHLY
Shape
US Flag

PNK

6B

Drug Manufacturers - General

Next Earning date - 30 Oct 2024

6B

Drug Manufacturers - General

Next Earning date - 30 Oct 2024

4.25USD
Shape0.03 ( 0.71%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

34%

Quote Panel

Shape
Updated October 24, 2024
1W -5.17 % 1M -5.38 % 3M -12.45 % 1Y -25.83 %

Key Metrics

Shape
  • Market Cap

    5.99B


  • Shares Outstanding

    1.41B


  • Share in Float


  • Dividende

    0.17


  • Earning Date

    30 Oct 2024


  • Price Target

    4.25


  • Average Volume

    174804


  • Beta

    0.179


  • Range

    4.2-6.43


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.ono-pharma.com


  • Sector

    Healthcare


Fundamentals

Shape

2.74x

P/E Ratio

1.82x

P/S Ratio

0.37x

P/B Ratio

0.2

Debt/Equity

24.2%

Net Margin

$0.6

EPS

How OPHLY compares to sector?

P/E Ratio

Relative Strength

Shape

OPHLY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$471B

Shape300%

2025-Revenue

$52.08

Shape-1%

2025-EPS

$166B

Shape374%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

UBS

downgrade

Previous: Not converted

2024-08-30

Now: Sell

Citigroup

downgrade

Previous: Not converted

2024-05-27

Now: Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+16%

0.16
vs 0.13

Q4.22

arrow
arrow

+393%

0.53
vs 0.11

Q1.23

arrow
arrow

+198%

0.26
vs 0.09

Q2.23

arrow
arrow

+205%

0.45
vs 0.15

Q3.23

arrow
arrow

+280%

0.59
vs 0.16

Q4.23

arrow
arrow

+3%

0.54
vs 0.53

Q1.24

arrow
arrow

-70%

0.08
vs 0.26

Q2.24

arrow
arrow

-27%

0.33
vs 0.45

Q3.24

arrow
arrow

+2767%

16.92
vs 0.59

Q4.24

arrow
arrow

+2402%

13.56
vs 0.54

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+27%

110B  vs 86.7B

Q4.22

arrow
arrow

+26%

122.3B  vs 97.4B

Q1.23

arrow
arrow

+20%

108.2B  vs 89.9B

Q2.23

arrow
arrow

+12%

120B  vs 106.7B

Q3.23

arrow
arrow

+26%

138.7B  vs 110B

Q4.23

arrow
arrow

+7%

131.2B  vs 122.3B

Q1.24

arrow
arrow

+4%

112.8B  vs 108.2B

Q2.24

arrow
arrow

-2%

117.7B  vs 120B

Q3.24

arrow
arrow

-11%

123.4B  vs 138.7B

Q4.24

arrow
arrow

-4%

125.9B  vs 131.2B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.04

Q4.22

arrow
arrow

+5%

0.05
vs 0.05

Q1.23

arrow
arrow

+2%

0.02
vs 0.05

Q2.23

arrow
arrow

+4%

0.04
vs 0.02

Q3.23

arrow
arrow

+5%

0.05
vs 0.04

Q4.23

arrow
arrow

+5%

0.05
vs 0.05

Q1.24

arrow
arrow

+2%

0.02
vs 0.05

Q2.24

arrow
arrow

+3%

0.03
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

2

2
vs 3

-33%

Q4.22

arrow
arrow

4

4
vs 2

100%

Q1.23

arrow
arrow

3

3
vs 4

-25%

Q2.23

arrow
arrow

5

5
vs 3

67%

Q3.23

arrow
arrow

5

5
vs 5

NA

Q4.23

arrow
arrow

4

4
vs 5

-20%

Q1.24

arrow
arrow

3

3
vs 4

-25%

Q2.24

arrow
arrow

2

2
vs 3

-33%

Earnings Growth

Latest News